Seattle, WA, United States of America

Brian J Reardon

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Zymogenetics, Inc.. Active years: 2010.


% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian J Reardon: Innovator in FGF18 Production

Introduction

Brian J Reardon is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the production of FGF18. His innovative work has led to advancements in expression systems that enhance the large-scale production of this important protein.

Latest Patents

Reardon holds a patent for "FGF18 production in prokaryotic hosts." This patent describes expression vectors and methods that utilize an expression system for the large-scale production of FGF18. The vectors incorporate the FGF18 coding sequence with specific nucleotide changes to optimize codons and mRNA secondary structure for translation. Using these expression vectors, the FGF18 gene was produced at levels exceeding 1 g/L in fed-batch fermentation.

Career Highlights

Brian J Reardon is currently associated with Zymogenetics, Inc., where he continues to push the boundaries of biotechnological research. His work has been instrumental in developing efficient methods for protein production, which are crucial for therapeutic applications.

Collaborations

Reardon has collaborated with esteemed colleagues such as Susan H Julien and Chung-Leung Chan. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Brian J Reardon is a prominent figure in the field of biotechnology, with a focus on FGF18 production. His contributions through patents and collaborations have significantly impacted the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…